| GTO ID | GTC3029 |
| Trial ID | NCT05372692 |
| Disease | Ovarian Cancer |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LD013 |
| Recruitment status | Recruiting |
| Title | Study of LD013 in Subjects With Refractory or Relapsed Mesothelin -Positive Ovarian Cancer |
| Year | 2022 |
| Country | China |
| Company sponsor | Weijia Fang, MD |
| Other ID(s) | ZhaoPeng |
| Cohort 1 | |||||||||
|
|||||||||